CALR, calreticulin, 811

N. diseases: 487; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.020 Biomarker disease BEFREE Pegvisomant is a more cost-effective alternative for the treatment of acromegaly in FG SSA-resistant patients in the Spanish NHS. 31055976 2019
CUI: C0001206
Disease: Acromegaly
Acromegaly
0.020 Biomarker disease BEFREE Oral glucose tolerance testing (OGTT) was performed on 64 newly diagnosed and treatment-naïve patients with acromegaly both at pretreatment and 3 months after initiation of treatment with long-acting SSA. 29853879 2018